- Supply TypeExporter, Supplier, Retailer, Distributor
- Preferred Buyer Location All Countries Except India
Hernix Neratinib is an anti-cancer medication, specifically a tyrosine kinase inhibitor, used for the extended adjuvant treatment of early-stage HER2-overexpressed/amplified breast cancer in adults. It is given after patients complete adjuvant trastuzumab-based therapy. The medication helps reduce the risk of recurrence in this type of breast cancer.